AI Drug Discovery & Protein/Molecule Design Software
Causaly
Biomedical evidence and reasoning for R&D
- SF Score
- 7.6/10
- Pricing
- Contact sales
Compare tools
2 of 4 tools selected
AI Drug Discovery & Protein/Molecule Design Software
Chai Discovery
Molecular structure prediction for discovery research
- SF Score
- 7.3/10
- Pricing
- Contact sales
Add third toolCompare up to 4 side by side
Compare features, strengths, trade-offs, and best-fit use cases.
Comparing
Where each one leads
Read straight from the published figures below — not a ranking, and not a recommendation.
Highest SF Score
Causaly7.6/10
2 of 2 are scored
At a glance
The short version
The facts each tool publishes, lined up so you can scan down a column. Anything the catalog does not establish is marked as such rather than counted against the tool.
Causaly
- SF Score
- 7.6 / 10
- Free plan
- Not offered
- Category
- AI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design Software
Chai Discovery
- SF Score
- 7.3 / 10
- Free plan
- Not offered
- Category
- AI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design Software
Key differences
Where these tools actually diverge
The decision dimensions that separate this set, with each tool's own position stated plainly. No winner is declared — fit depends on your workflow.
Positioned for
Causaly
AI Drug Discovery & Protein/Molecule Design Software
Chai Discovery
AI Drug Discovery & Protein/Molecule Design Software
Pricing model
Causaly
Contact sales
Chai Discovery
Contact sales
SoftFinders Score
Causaly
7.6 / 10
Chai Discovery
7.3 / 10
Feature comparison
Capability matrix
Grouped by area. Every state carries a word as well as a colour, and anything the catalog has not established stays neutral rather than counting as a missing feature.
1 row differs 8 identical
| Capability | | |
|---|---|---|
| Overview | ||
| SF Score | 7.6 / 10Value | 7.3 / 10Value |
| Pricing model | CustomValue | CustomValue |
| Free plan | No | No |
| Category | AI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design SoftwareValue | AI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design SoftwareValue |
| Core features | ||
| Partner WorkflowsWorkflows for pharma partner collaborations | Yes | Yes |
| Target DiscoveryIdentifies potential drug targets from biological data | Yes | Yes |
| Molecule DesignGenerates and ranks small molecule candidates | Yes | Yes |
| Protein ModelingPredicts and designs protein structures | Yes | Yes |
| Knowledge GraphConnects biological and chemical knowledge sources | Yes | Yes |
Scroll the matrix sideways to see every column.
Listed by one tool only
8 capabilities are published by a single tool in this set. That does not mean the others lack them — only that the catalog has not established an answer either way.
- Scientific RAGRetrieves and ranks evidence with biomedical context
- Private Data FabricBrings proprietary research into governed scientific analysis
- Discover Research WorkspaceAnswers biomedical questions with structured, cited evidence
- Lab IntegrationConnects discovery insights with wet-lab workflows
- Scientific Audit ControlsAdds checkpoints, audit trails, and access controls
- Virtual ScreeningScreens compound libraries against targets
- Modified Epitope TargetingHandles ligands, glycans, and other PTMs
- Multimodal Structure PredictionPredicts proteins, ligands, DNA, RNA, and glycans
Use cases
What each tool is built for
The workflows each tool publishes for itself. Cards appear only for tools that list use cases.
Causaly
- Identify drug targets from biology data
- Accelerate molecule design cycles
- Support protein engineering programs
- Mine literature for research signals
Chai Discovery
- Accelerate molecule design cycles
- Support protein engineering programs
- Mine literature for research signals
- Run virtual screens against targets
- Collaborate with pharma partners
+4 more on the Chai Discovery profile
Pros & cons
Strengths and compromises
Each tool's published strengths and the compromises that come with them, as supplied — not scored or ranked against each other. Longer lists fold; nothing is left out.
Causaly
Pros
- Biomedical evidence and reasoning at scale
- Stays focused on real drug discovery buyer problems
- Scales to organization-wide healthcare rollouts
- ISO 27001 certified
- Client data excluded from model training
- Microsoft Copilot and Teams access available
- 500M biomedical facts support evidence retrieval Causaly
Cons
- Value tied to research workflow integration
- Drug success still depends on downstream trials
- Pricing is sales-led and needs scoping upfront
- Custom workflows involve Causaly scientific experts
- Public pricing requires contacting sales
- Causaly content cannot populate internal databases
- Custom data types may need professional services
- Licenses are capped by authorized-user limits
Chai Discovery
Pros
- Frontier molecular structure prediction models
- Built specifically for drug discovery teams, not bolt-on AI
- Scales to organization-wide research rollouts
- Antibody hit rates exceed 10%
- Miniprotein hit rates exceed 50%
- Discovery cycles can reach two weeks
- Chai-1 permits commercial local deployment
Cons
- Mostly research-facing rather than packaged product
- Drug success still depends on downstream trials
- Pricing is sales-led and needs scoping upfront
- Chai-2 commercial access requires application
- Academic Chai-2 access remains limited
- Chai-1 local inference needs capable GPU
- Chai-1 inference currently lacks multi-GPU support
- Chai-1 inputs are capped at 2,048 tokens github.com
Pricing
What each one costs
Published pricing signals only. Where a tool has not established a price, that is what it says — never a zero and never "free".
Causaly
- Model
- Custom
Contact Sales
See full pricingChai Discovery
- Model
- Custom
Contact Sales
See full pricingNext step
Ready to try one?
A matrix narrows the field; a free trial settles it. Open whichever tool fits your workflow best, or start a different comparison.
Compare another set of tools